CDC supports activities carried out by state and local health departments, partners, and investigators to combat antibiotic resistance. CDC supports most of these activities through the Antibiotic Resistance (AR) Solutions Initiative, and leverages investments from successful programs across the agency for maximum efficiency. These activities are funded through different mechanisms, some of which are listed below.
CDC funding solicitation and award announcements change from year to year. Visit FedBizOppsexternal icon to find current opportunities and exact deadlines throughout the Federal Government.
- Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Cooperative Agreement: Supports antibiotic resistance activities in every state, including state and local laboratory and epidemiological expertise. Learn more on CDC’s ELC website.
- Broad Agency Announcement (BAA): Contracts with educational institutions, nonprofit organizations, state and local government, and private industry for research and development to identify and evaluate strategies to combat antibiotic resistance. Learn more on CDC’s BAA website.
- Global Healthcare Detection and Response: An international, five-year funding opportunity for partners with experience in healthcare infection detection and response, and/or antibiotic and antifungal resistance across the One Health spectrum. Learn more on the National Center for Emerging and Zoonotic Infectious Diseases website.
- Modeling Infectious Diseases in Healthcare Network (MInD – Healthcare): Established a virtual laboratory where researchers can investigate factors that drive spread of healthcare-associated infections and simulate multiple prevention strategies to estimate their benefits in a timely and cost-effective manner. Learn more on CDC’s MInD – Healthcare website.
- Prevention Epicenters Program: Develop and test innovative approaches to preventing infections and improving patient safety in healthcare settings. Learn more on CDC’s Prevention Epicenters website.
- Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD): Requests research and other collaborative proposals from organizations to develop and conduct research and innovative prevention projects related to safety in healthcare settings. Learn more on CDC’s SHEPheRD website.
- Small Business Innovation Research (SBIR) Program: Targets innovations in diagnostics, surveillance, and public health. Learn more on CDC’s SBIR website.
|Funding Mechanism||Solicitation Announced|
|ELC Cooperative Agreement||March, annually|
|Global Healthcare Detection and Response||April 2021|
|MInD – Healthcare||2017; next announcement expected 2020|
|Prevention Epicenters Program||2016; next announcement expected in 2021|
|SHEPheRD Program||2016; next announcement expected in 2021|
|SBIR Program||January, annually|